Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (1107)

« Back to Publications

Predicting trajectories of illness using RNA velocity of whole blood.

Dunican C. et al, (2026), Nat Commun, 17

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

Jones E. et al, (2026), J Immunol, 215

Global population structure and phase variation of serotype 12F Streptococcus pneumoniae following the introduction of pneumococcal conjugate vaccine

Huynh TNM. et al, (2026)

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.

Zhang Y. et al, (2026), EClinicalMedicine, 94

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Walker J. et al, (2026), PLoS Negl Trop Dis, 20

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), Lancet Infect Dis

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Cheliotis KS. et al, (2026), Vaccine, 75

Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.

Hausdorff WP. et al, (2026), Vaccine, 75

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

Liatsikos K. et al, (2026), Lancet Microbe, 7

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

Dold C. et al, (2026), Mol Ther

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections

Hagedoorn N. et al, (2026)

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections

Hagedoorn NN. et al, (2026)

Nasal Gene Expression in ART-Naive Adults with HIV and Pulmonary Tuberculosis in Uganda.

Khambati N. et al, (2026), medRxiv

A risk to child health: confusion and concern over changes to US vaccine policy.

Pollard AJ. and Plotkin S., (2026), Lancet, 407, 553 - 556

Causes of Fever in a Cohort of Nepali Children and the Potential Impact of Molecular Testing During a Dengue Fever Outbreak.

O'Reilly PJ. et al, (2026), Pediatr Infect Dis J

Load More

1
2
3
4
5
6
7
...
»